Clinical trial
Evaluating the Neurophysiologic and Clinical Effects of Single-Dose Baclofen, Roflumilast, Memantine, and Placebo in Fragile X Syndrome
NCT05418049 is registered in ClinicalTrials.gov with Children's Hospital Medical Center, Cincinnati as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Evaluating the Neurophysiologic and Clinical Effects of Single-Dose Baclofen, Roflumilast, Memantine, and Placebo in Fragile X Syndrome
- Lead sponsor
- Children's Hospital Medical Center, Cincinnati
- Phase
- Phase 2
- Overall status
- Active, not recruiting
- Start date
- September 8, 2022
- Completion date
- March 5, 2026
- Enrollment
- 45 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.